PI3K/AKT/mTOR通路
辐射敏感性
蛋白激酶B
自噬
癌症研究
癌症
RPTOR公司
细胞凋亡
生物
化学
癌细胞
细胞生物学
信号转导
放射治疗
医学
内科学
生物化学
遗传学
作者
Alireza Mardanshahi,Nasrin Abbasi Gharibkandi,Samaneh Vaseghi,Seyed Mohammad Abedi,Sajjad Molavipordanjani
标识
DOI:10.1007/s11033-021-06607-3
摘要
INTRODUCTION Radiotherapy is one of the most common types of cancer treatment modalities. Radiation can affect both cancer and normal tissues, which limits the whole delivered dose. It is well documented that radiation activates phosphatidylinositol 3-kinase (PI3K) and AKT signaling pathway; hence, the inhibition of this pathway enhances the radiosensitivity of tumor cells. The mammalian target of rapamycin (mTOR) is a regulator that is involved in autophagy, cell growth, proliferation, and survival. CONCLUSION The inhibition of mTOR as a downstream mediator of the PI3K/AKT signaling pathway represents a vital option for more effective cancer treatments. The combination of PI3K/AKT/mTOR inhibitors with radiation can increase the radiosensitivity of malignant cells to radiation by autophagy activation. Therefore, this review aims to discuss the impact of such inhibitors on the cell response to radiation.
科研通智能强力驱动
Strongly Powered by AbleSci AI